JP2021515541A5 - - Google Patents
Info
- Publication number
- JP2021515541A5 JP2021515541A5 JP2020542228A JP2020542228A JP2021515541A5 JP 2021515541 A5 JP2021515541 A5 JP 2021515541A5 JP 2020542228 A JP2020542228 A JP 2020542228A JP 2020542228 A JP2020542228 A JP 2020542228A JP 2021515541 A5 JP2021515541 A5 JP 2021515541A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- amino acid
- acid sequence
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1803746.5 | 2018-03-08 | ||
| GBGB1803746.5A GB201803746D0 (en) | 2018-03-08 | 2018-03-08 | PD1 binding agents |
| GBGB1813405.6A GB201813405D0 (en) | 2018-03-08 | 2018-08-16 | PD1 binding agents |
| GB1813405.6 | 2018-08-16 | ||
| PCT/EP2019/055927 WO2019170898A1 (en) | 2018-03-08 | 2019-03-08 | Pd1 binding agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021515541A JP2021515541A (ja) | 2021-06-24 |
| JP2021515541A5 true JP2021515541A5 (OSRAM) | 2022-03-15 |
Family
ID=61972796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542228A Pending JP2021515541A (ja) | 2018-03-08 | 2019-03-08 | Ｐｄ１結合剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10858435B2 (OSRAM) |
| EP (1) | EP3762419A1 (OSRAM) |
| JP (1) | JP2021515541A (OSRAM) |
| CN (1) | CN111819199A (OSRAM) |
| AU (1) | AU2019229676A1 (OSRAM) |
| CA (1) | CA3092174A1 (OSRAM) |
| GB (2) | GB201803746D0 (OSRAM) |
| IL (1) | IL277135A (OSRAM) |
| SG (1) | SG11202008246VA (OSRAM) |
| WO (1) | WO2019170898A1 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3702373T (lt) | 2013-09-13 | 2022-11-10 | Beigene Switzerland Gmbh | Anti-pd1 antikūnai ir jų naudojimas terapijai ir diagnostikai |
| TWI726608B (zh) | 2014-07-03 | 2021-05-01 | 英屬開曼群島商百濟神州有限公司 | 抗pd-l1抗體及其作為治療及診斷之用途 |
| WO2018007885A1 (en) | 2016-07-05 | 2018-01-11 | Beigene, Ltd. | COMBINATION OF A PD-l ANTAGONIST AND A RAF INHIBITOR FOR TREATING CANCER |
| AU2017313085B2 (en) | 2016-08-19 | 2024-06-20 | Beone Medicines I Gmbh | Use of a combination comprising a Btk inhibitor for treating cancers |
| WO2018137681A1 (en) | 2017-01-25 | 2018-08-02 | Beigene, Ltd. | Crystalline forms of (s) -7- (1- (but-2-ynoyl) piperidin-4-yl) -2- (4-phenoxyphenyl) -4, 5, 6, 7-tetrahy dropyrazolo [1, 5-a] pyrimidine-3-carboxamide, preparation, and uses thereof |
| KR102757960B1 (ko) | 2017-06-26 | 2025-01-22 | 베이진 엘티디 | 간세포암(hepatocellular carcinoma: HCC)에 대한 면역 치료 |
| CN111801334B (zh) | 2017-11-29 | 2023-06-09 | 百济神州瑞士有限责任公司 | 使用包含btk抑制剂的组合治疗惰性或侵袭性b-细胞淋巴瘤 |
| GB201803745D0 (en) | 2018-03-08 | 2018-04-25 | Ultrahuman Eight Ltd | PD1 binding agents |
| GB201914747D0 (en) | 2019-10-11 | 2019-11-27 | Ultrahuman Eight Ltd | PD1 and vegfr2 dual-binding agents |
| EP4045023A4 (en) * | 2019-10-15 | 2023-09-13 | Diverse Biotech, Inc. | CONJUGATED MOLECULES |
| MA59827B1 (fr) | 2020-05-26 | 2024-10-31 | Boehringer Ingelheim International Gmbh | Anticorps anti-pd-1 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2161336T5 (pl) * | 2005-05-09 | 2017-10-31 | Ono Pharmaceutical Co | Ludzkie przeciwciała monoklonalne przeciwko białku Programmed Death 1 (PD-1) oraz sposoby leczenia raka z zastosowaniem samych przeciwciał anty-PD-1 lub w połączeniu z innymi środkami immunoterapeutycznymi |
| LT3702373T (lt) * | 2013-09-13 | 2022-11-10 | Beigene Switzerland Gmbh | Anti-pd1 antikūnai ir jų naudojimas terapijai ir diagnostikai |
| HUE046249T2 (hu) * | 2013-12-12 | 2020-02-28 | Shanghai hengrui pharmaceutical co ltd | PD-1 antitest, antigén-kötõ fragmense, és gyógyászati alkalmazása |
| DK3356411T3 (da) * | 2015-10-02 | 2021-09-06 | Hoffmann La Roche | Bispecifikke antistoffer, der er specifikke for PD1 og TIM3 |
| GB201803745D0 (en) | 2018-03-08 | 2018-04-25 | Ultrahuman Eight Ltd | PD1 binding agents |
-
2018
- 2018-03-08 GB GBGB1803746.5A patent/GB201803746D0/en not_active Ceased
- 2018-08-16 GB GBGB1813405.6A patent/GB201813405D0/en not_active Ceased
-
2019
- 2019-03-08 AU AU2019229676A patent/AU2019229676A1/en not_active Abandoned
- 2019-03-08 SG SG11202008246VA patent/SG11202008246VA/en unknown
- 2019-03-08 CN CN201980017416.5A patent/CN111819199A/zh active Pending
- 2019-03-08 EP EP19710389.8A patent/EP3762419A1/en not_active Withdrawn
- 2019-03-08 JP JP2020542228A patent/JP2021515541A/ja active Pending
- 2019-03-08 WO PCT/EP2019/055927 patent/WO2019170898A1/en not_active Ceased
- 2019-03-08 CA CA3092174A patent/CA3092174A1/en active Pending
-
2020
- 2020-06-25 US US16/912,023 patent/US10858435B2/en not_active Expired - Fee Related
- 2020-09-03 IL IL277135A patent/IL277135A/en unknown
- 2020-11-19 US US16/952,678 patent/US20210101981A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519100A5 (OSRAM) | ||
| JP2021515542A5 (OSRAM) | ||
| JP2021513323A5 (OSRAM) | ||
| JP2024513921A5 (OSRAM) | ||
| JP7734753B2 (ja) | 抗ｃｌｄｎ６抗体およびその使用 | |
| JP2022553908A5 (OSRAM) | ||
| JP2021516537A5 (OSRAM) | ||
| JP2019201643A5 (OSRAM) | ||
| FI4041763T3 (fi) | Pd1:tä ja vegfr2:ta kaksoissitovia aineita | |
| JP2017149720A5 (OSRAM) | ||
| RU2017145150A (ru) | Антитело против pdl-1, его фармацевтическая композиция и применение | |
| HRP20200583T1 (hr) | Protutijela koja neutraliziraju gp120 i njihova upotreba | |
| JP2020514277A5 (OSRAM) | ||
| JP2018522541A5 (OSRAM) | ||
| JP2018506961A5 (OSRAM) | ||
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2022533538A5 (OSRAM) | ||
| JP2021534797A5 (OSRAM) | ||
| JP2024540148A5 (OSRAM) | ||
| JP2020513759A5 (OSRAM) | ||
| JP2021515544A5 (OSRAM) | ||
| JP2023542209A5 (OSRAM) | ||
| JP2021514654A5 (OSRAM) | ||
| JP2022517216A5 (OSRAM) | ||
| JP2025517737A5 (OSRAM) |